Tag: Irish College of General Practitioners

  • Is General Practice a Victim of Pandemic?

    I loved working for the NHS (National Health Service), especially as it was configured in Bradford, West Yorkshire. Bradford was a health action zone, and probably still is due to its high level of social deprivation. This meant it got more funding for health and social initiatives.

    Darndale, Dublin or Moyross, Limerick would be areas with similar issues. The practices in Bradford were large and covered virtually everything except performing major surgeries and delivering babies, meaning there was an eclectic mix of health professionals, all under the same roof. This was referred to as a ‘primary care team’. A team?

    After completing my undergraduate training in Dublin I arrived under the impression that being a GP was essentially a solo effort, a bit like being a snooker player.

    In his own eyes the GP is the hero, even if in Ireland he is a failed consultant in other people’s view. Not so in the NHS, and certainly not in Bradford, where GPs were part of a multidisciplinary team approach to the provision of health services. Each person was a cog in wheel that contained management, administration, nursing, occupational therapy, physiotherapy and community pharmacy services. They even held meetings, spoke to each other civilly and advice flowed in various directions. How radical!

    On a wider scale, local practices provided many of the out-patient services traditionally provided by hospitals including cardiology, neurology, rheumatology and chronic disease management; they even carried out minor surgery and endoscopies. GPs were encouraged to upskill to become what they called ‘GPs with special interests’ or GPSI (pronounced Gypsy). All of this occurred in close proximity to their patients and in familiar surroundings. These practices were based in large urban centres, although I would imagine it would have been difficult to replicate this model in rural areas with widely dispersed populations.

    Unemployed outside a workhouse in London in 1930.

    Beveridge Report

    The NHS emerged in a society with a different history to Ireland’s. The 1942 Beveridge report highlighted that urban poverty was widespread in the U.K., as George Orwell’s account in The Road to Wigan Pier bears testament. One can get all misty-eyed about Beveridge’s recognition of the plight of the working class; the reality was a fear that workers’ poor health would impact on profits, and might turn revolutionary.

    Nevertheless, the post-War drive to correct some of these deficits lay behind the birth of the Welfare State, including the establishment of the NHS in 1948. This was strenuously resisted by the medical profession, much as the profession in Ireland, along with the Catholic Church, were resistant to Noel Browne’s Mother and Child Scheme. More latterly the mere mention of ‘Sláintecare’ induces apoplectic rage among certain members of the ‘caring’ profession.

    This may seem naïve, but I fail to see what’s wrong with a universal health service, ’free at the point of entry from the cradle to the grave’, paid for out of taxation revenue and borrowings; this is a service that encourages the utilisation of all health-related services in a country, public and private, for all citizens, based not on ability to pay, but need. But apparently this isn’t a good idea.

    I have come across many ideas that were thought not to be good ideas in my twenty-seven years of practice, but few had credible reasons for their outright rejections. Chronic disease management, i.e. diabetes, heart failure, COPD or renal failure should be undertaken by a person known to the patient – i.e. a GP – living in close proximity to where they live.

    ‘Too Busy’

    This has been the bread and butter work of GPs in the U.K. since the 1990s, but apparently in Ireland during the 2000s this wasn’t a good idea, because we were ‘too busy’. Doing what I wonder?

    Integrated services would allow GPs to order investigations directly. In Ireland at present, if, for example, a chap without health insurance injures his knee playing Sunday football and his GP thinks it could be a torn cartilage, he will have to wait up to two years to see an orthopaedic surgeon. He is then put on a waiting list for perhaps another year, until finally he has his MRI scan and discovers he has a torn cartilage.

    By that time, however, he is no longer playing football and is twenty kilos overweight, having spiralled into an unhealthy lifestyle. To add insult to injury he will receive a letter from the hospital asking if he wishes to remain on the waiting list for his knee operation, by which stage he might as well get in the queue for a knee replacement.

    Big Pharma

    Nowadays, it’s not a good idea to refuse to meet pharmaceutical reps when they call to the practice. Having trained in Bradford – where none of the practices or the training scheme’s educational events gave access to reps – I thought that it was reasonable to turn them away. We didn’t meet reps selling toilet rolls or coffee, so why meet representatives of multibillion dollar pharmaceutical corporations? Such companies spend more on advertising and marketing than research because they know how it works.

    Alas, we dopey doctors assume they are sharing their scientific data with us whilst buying us lunch, giving us pens (with names of drugs emblazoned on them), stationary, wall clocks, mugs etc. So, they do share ’their’ science, the bits of their research that shows their product in a good light, not the science or the research warts, or heart attacks, and all.

    After all, we G.P.s are trained professionals and would never be influenced by such inducements. Forget about the science demonstrating a correlation between drug prescribing and frequency of pharmaceutical rep visits.

    Cosy World

    A cosy world of Irish general practice featuring golf, rugby and tweed had been frozen in time until 2008. The GMS contract which began in 1970s paid well, but we still had our ‘privates’. In other parts of the English-speaking world ‘privates’ usually refers to one’s genitalia, but in an Irish GP setting this refers to the paying customer.

    In some practices private patients are given preferential access to appointments. Invariably, this will involve nothing more than prescribing an antibiotic for a cold. Such patients usually have their own cardiologist or several oncologists they refer to using their first names. However, from 2008 onwards when the International Monetary Fund invaded Ireland and took control of the purse strings, the government of the day unilaterally took 35% off the GMS contract payments. Then the privates became more important, but these patients were increasingly hard up too with the world’s economy in a mess.

    The next few years for me remain a blur. My recollections arrives through the haze of mental illness and stress brought on by a Celtic Tiger mortgage, business partnership shenanigans, and yo-yoing emigration-immigration, amongst other adventures.

    Image (c) Daniele Idini

    Pandemic

    Fast forward to 2020 and the unknown quantity that was the Sars-CoV2 escape from Wuhan’s virology research centre – known as the Wuhan Wet Market dose to some, depending on your trust in media, governments and power elites.

    Then the WHO advised GPs via august bodies such as the Irish College of General Practitioners to do nothing, as there were no treatments despite it being a deadly pandemic. Furthermore, we didn’t even need to see patients. We locked our doors, sat by the phone, ‘stayed safe by staying apart,’ among a litany of other trite statements.

    It was heartening to note on some well-known GP websites that some practitioners were one step ahead of WHO/HIQA/NPHET insofar as they immediately sensed a threat to ‘the privates’. Not as an unwanted symptom of a Sars-CoV2 infection, but as a result of the hatches being battened down. How could the privates access their GPs and more importantly pay them?

    The unelected and widely disrespected government with its GP-trained Taoiseach knew instinctively what to do. More accurately Leo Varadkar knew what to do. He found the answer to this most perplexing question and saved the day. Make everyone private. GMS patients ringing up resulted in a fee, privates ringing up resulted in a fee from the government.

    So the gravy train sloshed its merry way through the pandemic. An entire profession was bought, and continues to be bought by vast sums of money for examining patients that one is already being paid for, vaccinating all and sundry against influenza, Sars-CoV2-twice or is it three times, who knows, who cares, the money spigot is stuck on maximum flow.

    Money that was not available up to 2020 is now flowing like goodies from the proverbial cornucopia. This has bought compliance with ways of treating people that run counter to the codes of practice of any good doctor.

    Practices are now treating patients like lepers, creating nonsensical plastic barriers, one way passes through surgeries, discouraging unvaccinated patients, disrespecting patient autonomy, and offering a paternalism reminiscent of the Victorian era. But worst of all is a refusal to treat patients in the early stages of Sars-CoV2, regardless of how medically vulnerable they may be because of ignorance and hubris.

    This is what buying a profession produces.

    Image: Daniele Idini.

    Eau de BS

    Born and reared in a working class Dublin area with a healthy disrespect for all authority, I have always been a contrarian. That disrespect has served me well. So, when I hear people in authority asking citizens to pull together or to do deeds for the good of the nation I instinctively smell eau de BS.

    Supposedly for the good of the nation, we are creating a society that is comfortable with meaningless segregation based on vaccination status that is supported by the medical profession. We even have the prospect of hospitals taking young people off transplant lists and families being refused access to a dying loved one in a care home. Now we are witnessing a clamour for a dubiously effective pharmaceutical product to be inflicted on children as young as five.

    The medical profession has allowed one of the highest levels of trust to be stolen by greedy fools who use it to ensure people think that their products can also be trusted. The medical profession has become avaricious, self-serving, vindictive, patient-averse, opinionated and authoritarian, and is failing to foster the doctor-patient relationship.

    I fear that relationship which is the bedrock of general practice has been irrevocably damaged. What need then will there be for GPs if artificial intelligence can deliver the information in an up-to-date, rational, non-judgemental and timely fashion in the comfort of anyone’s home?

    It seems that when this older generation pass into retirement, a tech savvy generation will not want what they never really had: a genuine doctor-patient relationship.

    Featured Image: Aneurin Bevan talking to a patient at Park Hospital, Manchester, the day the NHS came into being in 1948.

  • Could Ivermectin End the Pandemic?

    The bacterium streptomyces avermitilis was discovered by Satoshi Omura at the Kitasato Institute in Japan in conjunction with William C. Campbell at MSD (Merck, Sharpe and Dome) in the early 1970s. From this compound the medicine Ivermectin was developed. Ever since, it has proved a wonder drug for the treatment of parasites in humans and animals.

    Most of these infections occur in Africa and Latin America, but it was nevertheless a lucrative drug for MSD. Nonetheless, in 1987 they provided the drug to the world free of charge as the Kitasato Institute gave up rights to any further royalties from its sale. This was an exceptionally generous gesture as it was a $1 billion per year product, and had been for several years. Its extensive and widespread use in humans has been described by Chris Whitty, Chief Scientific Advisor to the British government throughout the COVID-19 pandemic as ‘a drug with a good safety profile’, with a serious adverse drug reaction rate of 1/800,000

    Another paper says ‘Ivermectin was generally well tolerated with no indication of associated CNS (central nervous system) toxicity for doses up to 10 times the highest FDA approved dose of 200mcg/Kg’. In a nutshell, it is a safe drug, in use for a long time, and the nuances of clinical usage are therefore known to many physicians.

    A recent paper from India using ivermectin as a preventative used 15mg on average, twice per month at a cost of $1.20 per month in healthcare workers resulted in a 72% reduction in infections. In a recent online enquiry to a wholesaler in India I was offered 100 x 3mg tablets for $12. Yet remarkably this same dose in Ireland would cost €100 per month.

    As is well known by now, in early 2020 the WHO alerted the world to a pandemic virus that apparently emerged out of China, a virus for which there was no known treatment available and which was most dangerous in elderly patients with underlying conditions.

    The illness presented with cold-like symptoms that after a period of between five and eight days could develop into severe respiratory symptoms, requiring hospitalisation and sadly in some cases leading to death.

    Guidelines for General Practitioners

    The Irish College of General Practitioners stated in their guidelines to general practitioners in April 2020: ‘Clinicians should be aware of the potential for some patients to rapidly deteriorate one week after illness onset’ (members access only: https://www.icgp.ie/speck/properties/asset-Interim Guidance for General Practitioners).

    The same document lists those conditions and age groups in which this is a possibility. It goes on to state that ‘no medications have shown any therapeutic benefit on the progress of Covid-19 pneumonia.’

    This advice has not been updated since April 2020. So ‘do nothing until the patient turns blue’ appears to be the invaluable advice from a national body sixteen months into this crisis. However, in the spring of 2020 if you were unfortunate enough to find yourself in a nursing home your blue pallor would not summon the arrival of a flashing blue light, but instead you would receive midazolam and morphine, both respiratory depressants, whilst you awaited the Grim Reaper.

    GPs were discouraged from examining their patients. Even the use of the stethoscope was deemed unnecessary. Shades of blue were everything. The ‘do nothing’ approach is still supported in the guidelines issued by HIQA in February 2021, despite over forty studies demonstrating the efficacy of ivermectin in the intervening period.

    HIQA Advice

    HIQA currently advise that ‘individuals do not prescribe or use interventions for the treatment of COVID-19 that do not meet the necessary minimum criteria’, but don’t outline what these criteria are.

    They go on to ensure that ‘practitioners are not criticised for not prescribing these interventions.’ This latter is a somewhat curious statement if a body is so confident that their evaluation of the evidence is above reproach.

    Yet William C. Campbell co-discoverer of Ivermectin with Satoshi Omura – with whom he shared the Nobel prize – in a speech to the Royal Irish Academy in April 2020 stated: ‘there is the possibility that a safe dosage of Ivermectin might reduce the rate of viral replication in the mammalian body, or affect the virus in other ways that might be revealed by further research.’

    Ivermectin (IVM) bound to a C. elegans GluClR.

    Fortunately for some Irish patients, a few brave GPs looked beyond this island for guidance. Asking doctors to do nothing, and specifically indicating certain actions that they should not take, is a restriction that disconcerts many experienced doctors, if not being a downright interference in the doctor-patient relationship.

    As GPs in the community we deal with people who are part of a family within a social setting. We are therefore cognisant of many features of health – which outsiders might consider superfluous to the ‘science of medicine’.

    Now I laugh each time someone juxtaposes those words, especially when I consider the absolute chaos that is general practice’s interaction with people. At the end of some consultations, I’m lucky to be able to spell my own name correctly, let alone apply the cold, steely, rational logic of science to solving any problems.

    But no matter how chaotic or complex, or even futile, medical interventions may be, one must never vanquish a patient’s hope. Even when close to death, hope – if not for further life at least for a peaceful death – is something the GP can bring to the situation.

    So who are these people in the ICGP or HIQA to say to GPs that there are no treatments available for their vulnerable patient who develops a SARS-CoV2 infection; to say ‘well let’s wait and see, and sure if you turn blue we’ll get an ambulance’?

    We won’t visit or examine you, and you won’t be coming to our surgeries, but we’ll look after you by proxy. So why were we as doctors advised to do nothing? Not even to try a cheap, effective and safe drug, if only to elicit the placebo effect?

    Criminal Charges

    In India WHO’s chief scientist Dr Soumya Swaminathan is facing criminal proceedings brought by the Indian Bar Association for disseminating disinformation about ivermectin and its effectiveness as a preventative and early treatment for SARS-CoV2 infection.

    Should those in HIQA who made recommendations to Irish doctors not face similar charges? Is this not a case of wilful blindness?

    In the USA two distinct groups of doctors-intensive care physicians lead by Drs Pierre Kory and Paul E. Marik set up the FLCCCA (Front Line Covid Critical Care Alliance), and community-based physicians led by Professor Peter McCullough of Texas A+M University, in conjunction with AAPS (American Association of Physicians and Surgeons), devised protocols in their respective fields using Ivermectin and other medications, deemed ineffective by the WHO.

    https://www.youtube.com/watch?v=dEmOCWOZPk8

    Their rationale was based on medical ethics and a professional desire to give their patients a fighting chance against this condition. They have faced vilification and attempted sanctions, as have doctors in Ireland who were simply trying to help their patients. And some patients even had the temerity to get better.

    I’m not sure what irked the Medical Council of Ireland more, the survival of the patients despite being given a HIQA/WHO proscribed substance, or some previous impotence at not being able to impose their second hand thoughts on all members of the medical profession.

    There is no money in helping patients as the current system is set up. One makes more money merely by ascertaining how ill someone is by using the phone. Even if these medications do nothing beyond the placebo effect why has there been a concerted effort to block the use of what has already been shown to be a relatively low risk intervention?

    Meta-Analysis

    The most recent Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines by Laurie, Bryant et al in the American Journal of Therapeutics found a 62% reduction in death in a meta-analysis of fifteen RCTs. It concludes:

    Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.

    The WHO’s own assessment of seven trials showing an 81% risk reduction was diminished in significance because of ‘imprecisions’ resulting in the WHO falling short of recommending the use of ivermectin. Fudge, fudge and more fudge.

    Let’s cut to the chase here with this and perhaps many other substances. There are powerful vested interests steering advisory bodies away from the evidence, buying up integrity and burying it in a deep dark place.

    The current vaccines are deemed to be the only safe and reliable treatments. This is ironic given that these products are all still in phase 3 trials, and safety data will not be fully available until late 2022 at the earliest.

    The fact is that emergency use authorisations (EUAs) issued by the FDA in America and the EMA in Europe are contingent on there being no other treatments available in a public health emergency deemed to be effective. This is about money, vast sums of money. It is about wilful blindness at the highest echelons of the WHO, national governments and so called scientific advisory bodies.

    It is about conflicts of interest, and the damaging and intellectually limiting dependency that science has placed on large corporations, and it would seem that now governments are in the same stranglehold.

    As it is often said, the first casualty of war is truth. Clearly this also applies to pandemics, where body counts mean money, power and influence. And as in war inflation of body counts has always been good for business. Death may evoke much front of camera hand wringing but behind the scenes there is even more palm rubbing and back slapping.